Document is current
Any future updates will be listed below
-
Authors
Staufer, Oskar https://orcid.org/0000-0002-8015-3132
Gupta, Kapil https://orcid.org/0000-0002-2115-3503
Hernandez Bücher, Jochen Estebano
Kohler, Fabian
Sigl, Christian
Singh, Gunjita
Vasileiou, Kate
Yagüe Relimpio, Ana
Macher, Meline https://orcid.org/0000-0002-9184-4959
Fabritz, Sebastian
Dietz, Hendrik https://orcid.org/0000-0003-1270-3662
Cavalcanti Adam, Elisabetta Ada https://orcid.org/0000-0003-0243-1552
Schaffitzel, Christiane https://orcid.org/0000-0002-1516-9760
Ruggieri, Alessia https://orcid.org/0000-0001-9981-3308
Platzman, Ilia
Berger, Imre https://orcid.org/0000-0001-7518-9045
Spatz, Joachim P. https://orcid.org/0000-0003-3419-9807
-
Funding
Funding for this research was provided by:
Max-Planck-Gesellschaft (Max Planck School Matter to Life)
Bundesministerium für Bildung und Forschung (MaxSynBio Consortium)
Deutsche Forschungsgemeinschaft (SFB 1129, Gottfried-Wilhelm-Leibniz Program)
- License Information
-
More Information
Article History
Received: 9 July 2021
Accepted: 24 January 2022
First Online: 14 February 2022
Competing interests
: C.B.S. and I.B. declare shareholding in Halo Therapeutics Ltd, related to this Correspondence. Patents describing materials, material compositions and formulations related to the present findings have been filed by O.S., K.G., I.P., J.P.S., C.B.S., and I.B. The remaining authors declare no competing interests.
